Sleep Treatments | Sleep Review
Onera Health, manufacturer of a European CE-marked patch for diagnosing sleep apnea and pending evaluation by the US FDA, recently closed EUR 10.5 million in Series B funding. As a result, the total funds raised so far have exceeded the mark of 24 million euros.
Led by Innovation Industries in close collaboration with Invest-NL and existing investors Jazz Pharmaceuticals, imec.xpand, BOM and 15th Rock, the company intends to raise the funds to conduct clinical trials and further commercialize its sleep diagnostic and monitoring products in Europe use and the United States.
“We will use the funding to gradually conduct larger clinical trials, our partnerships in the field of [European Union] and the United States and are accelerating product development to expand our sleep diagnostics and monitoring portfolio, ”said Ruben de Francisco, Founder, Chief Technology Officer and Interim CEO of Onera, in a press release. “This will make our products easier to commercialize and help the medical community provide the much-needed answers to millions of sleep disorders. We are very pleased with the strong support from investors who share our vision. “
Harm de Vries, partner at Innovation Industries, said in a press release: “We are very excited to lead this investment in Onera as the company is perfectly positioned to support the development of hospital quality care at home through its innovative sleep diagnostic products. We believe that Onera, with its world-class team, partners and breakthrough technology, will be able to democratize sleep medicine to the gold standard. “
Leo Holwerda, Director Capital of Invest-NL, said in a press release: “Our investment in Onera is another good example of how we are helping promising Dutch start-ups and innovative companies bring powerful technologies and solutions to market. “
Tom Vanhoutte, partner at imec.xpand, said in a press release: “We were convinced from the start that Onera had the potential to revolutionize the remote monitoring industry. We look forward to the continued success of Onera, enabled by this investment, in commercializing its products in Europe and the United States. “
Last month, Onera presented its first generation product at SLEEP 2021 and presented its latest research results to experts.
Onera recently relocated its headquarters to the Brainport region in Eindhoven, The Netherlands, while maintaining operations in the US.